Business Description
Touyun Biotech Group Ltd
NAICS : 339999
ISIN : BMG215AV1072
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | -0.08 | |||||
Debt-to-Equity | -8.38 | |||||
Debt-to-EBITDA | -1.71 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.85 | |||||
Beneish M-Score | -4.89 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.7 | |||||
3-Year EBITDA Growth Rate | -24.5 | |||||
3-Year EPS without NRI Growth Rate | 11 | |||||
3-Year FCF Growth Rate | 54.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 78.17 | |||||
9-Day RSI | 70.15 | |||||
14-Day RSI | 65.4 | |||||
6-1 Month Momentum % | -10.64 | |||||
12-1 Month Momentum % | -61.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.31 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 67.94 | |||||
Days Sales Outstanding | 64.77 | |||||
Days Payable | 66.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -1.52 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.34 | |||||
Operating Margin % | -51.49 | |||||
Net Margin % | -137.41 | |||||
FCF Margin % | -36.86 | |||||
ROE % | -506.42 | |||||
ROA % | -36.17 | |||||
ROIC % | -12.29 | |||||
ROC (Joel Greenblatt) % | -70.07 | |||||
ROCE % | -91.53 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.99 | |||||
EV-to-EBIT | -3.84 | |||||
EV-to-EBITDA | -3.84 | |||||
EV-to-Revenue | 5.19 | |||||
EV-to-FCF | -12.95 | |||||
Earnings Yield (Greenblatt) % | -26.04 | |||||
FCF Yield % | -12.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Touyun Biotech Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 169.54 | ||
EPS (TTM) (HK$) | -0.083 | ||
Beta | 0.41 | ||
Volatility % | 63.09 | ||
14-Day RSI | 65.4 | ||
14-Day ATR (HK$) | 0.014883 | ||
20-Day SMA (HK$) | 0.1675 | ||
12-1 Month Momentum % | -61.82 | ||
52-Week Range (HK$) | 0.131 - 0.42 | ||
Shares Outstanding (Mil) | 2,805.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Touyun Biotech Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Touyun Biotech Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Touyun Biotech Group Ltd Frequently Asked Questions
What is Touyun Biotech Group Ltd(HKSE:01332)'s stock price today?
When is next earnings date of Touyun Biotech Group Ltd(HKSE:01332)?
Does Touyun Biotech Group Ltd(HKSE:01332) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |